BORDEAUX, France Could AEF0117, a drug that has a novel mechanism of action in the brain, be the drug to fight cannabis addiction? Results from a phase 2a clinical trial that examined the efficacy of… [+5303 chars]Read More
Related Posts
SURMOUNT2 Tirzepatide Rings Up Major Weight Loss in T2D Medscape
Weekly tirzepatide injections in adults with type 2 diabetes and overweight or obesity safely produced a 12.8%-14.7% weight loss after 72 weeks in the SURMOUNT-2 pivotal trial.
One in Three Pro Football Players Think They Have CTE Medscape
One in Three Pro Football Players Think They Have CTE - Medscape
Intermittent Fasting Cutting Calories Give Same Weight Loss Medscape
Eating within a narrow time window is just as effective as counting calories, according to a new study from the University of Illinois, Chicago.
